GB2000441A - Therapeutic phenylglyoxylic acids and derivatives thereof - Google Patents

Therapeutic phenylglyoxylic acids and derivatives thereof

Info

Publication number
GB2000441A
GB2000441A GB7828326A GB7828326A GB2000441A GB 2000441 A GB2000441 A GB 2000441A GB 7828326 A GB7828326 A GB 7828326A GB 7828326 A GB7828326 A GB 7828326A GB 2000441 A GB2000441 A GB 2000441A
Authority
GB
United Kingdom
Prior art keywords
hydroxy
disease
halogen
hydrogen
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7828326A
Other versions
GB2000441B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER Ltd
Original Assignee
PFIZER Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER Ltd filed Critical PFIZER Ltd
Publication of GB2000441A publication Critical patent/GB2000441A/en
Application granted granted Critical
Publication of GB2000441B publication Critical patent/GB2000441B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/84Unsaturated compounds containing keto groups containing six membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/88Unsaturated compounds containing keto groups containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pharmaceutical compositions for use in treating a disease or condition attributable to reduced blood-flow, oxygen availability or carbohydrate metabolism in the cardiovascular system, or other disease or condition involving a defect in carbohydrate metabolism, for example, ischaemic heart disease, cardiac failure, cerebral insufficiency, obesity and diabetes comprise a compound of the formula: <IMAGE> wherein R is hydrogen, lower (i.e. C1-6) alkyl, hydroxy, lower alkoxy, lower alkylthio, lower (i.e. C2-6) alkanoyloxy or halogen; R<1> is hydrogen, lower alkyl or halogen, and R<2> is hydroxy or lower alkoxy; or, when R<2> is hydroxy, a pharmaceutically acceptable metal, ammonium, amine or amino acid salt thereof; together with a pharmaceutically acceptable diluent or carrier.
GB7828326A 1977-07-01 1978-06-29 Therapeutic agents Expired GB2000441B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2775677 1977-07-01

Publications (2)

Publication Number Publication Date
GB2000441A true GB2000441A (en) 1979-01-10
GB2000441B GB2000441B (en) 1982-01-06

Family

ID=10264753

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7828326A Expired GB2000441B (en) 1977-07-01 1978-06-29 Therapeutic agents

Country Status (17)

Country Link
US (1) US4219566A (en)
JP (1) JPS5414522A (en)
AU (1) AU507286B1 (en)
BE (1) BE868665A (en)
CA (1) CA1118353A (en)
DE (1) DE2828620C2 (en)
FR (1) FR2395753A1 (en)
GB (1) GB2000441B (en)
GR (1) GR70238B (en)
IE (1) IE47713B1 (en)
IL (1) IL55040A0 (en)
IT (1) IT1096860B (en)
LU (1) LU79902A1 (en)
NL (1) NL175030C (en)
PT (1) PT68239A (en)
SE (1) SE7806692L (en)
ZA (1) ZA783746B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60237968A (en) * 1985-03-08 1985-11-26 Kibun Kk Fiber aggregatelike fish-paste product

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE949521C (en) * 1955-01-09 1956-09-20 Merck Ag E Light stabilizers
US2868836A (en) * 1956-04-19 1959-01-13 Merck & Co Inc 2, 4-dihydroxy-3-methylphenylglyoxylic acid and derivatives thereof
US3754006A (en) * 1967-02-02 1973-08-21 Sterling Drug Inc Esters and amides of substituted glyoxylic acids
US3532737A (en) * 1967-02-02 1970-10-06 Sterling Drug Inc Esters of arylglyoxylic acids
US3830930A (en) * 1969-05-14 1974-08-20 Nickstadt Moeller Inc Labial compositions containing menthyl keto esters
US3657325A (en) * 1969-12-03 1972-04-18 Sterling Drug Inc Esters of substituted glyoxylic acids
US3818072A (en) * 1971-12-01 1974-06-18 Richardson Merrell Inc Alkyl substituted-benzoylacetates antilipemic agents
US3898269A (en) * 1972-07-03 1975-08-05 Rorer Inc William H Tetrahydronaphthylglyoxylic acids and esters
DE2335215B2 (en) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Use of a mixture in the fight against kidney disease leading to uremia

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
IL55040A0 (en) 1978-08-31
NL7807091A (en) 1979-01-03
BE868665A (en) 1979-01-02
NL175030C (en) 1984-09-17
DE2828620C2 (en) 1982-04-01
SE7806692L (en) 1979-01-02
FR2395753B1 (en) 1982-11-12
US4219566A (en) 1980-08-26
PT68239A (en) 1978-06-30
CA1118353A (en) 1982-02-16
GR70238B (en) 1982-09-01
FR2395753A1 (en) 1979-01-26
GB2000441B (en) 1982-01-06
DE2828620A1 (en) 1979-02-01
LU79902A1 (en) 1980-01-22
IT7825152A0 (en) 1978-06-29
ZA783746B (en) 1979-07-25
NL175030B (en) 1984-04-16
JPS5414522A (en) 1979-02-02
AU507286B1 (en) 1980-02-07
IE47713B1 (en) 1984-05-30
IT1096860B (en) 1985-08-26
IE781321L (en) 1979-01-01

Similar Documents

Publication Publication Date Title
ES8603455A1 (en) Blood-pressure lowering piperazine derivatives.
IE44246L (en) Heterocyclyloxypropanolamines
AU4950096A (en) Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
ES471981A1 (en) Quinazoline derivatives, process for their preparation, pharmaceutical preparations and their preparation.
HU9202227D0 (en) Method for producing triazolo-pyrimidine derivatives and pharmaceutical preparatives containing said compounds
HUT47551A (en) Process for producing nitric acid ester derivatives of oxazol- and thiazol- compounds
ATE46688T1 (en) AMINO-PROPANOL DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, USE THEREOF AND PHARMACEUTICALS CONTAINING THERM.
IE883048L (en) Polyamine derivatives as antineoplastic agents
GB2000441A (en) Therapeutic phenylglyoxylic acids and derivatives thereof
EP0381181A3 (en) A system for the controlled release of active agents and a process for its preparation
ES473534A1 (en) Analogues of prostacycline, methods for their preparation and their use in the treatment of circulatory diseases.
US4148920A (en) Therapeutic L- and DL- phenylglycines to treat diseases or disorders of reduced blood flow or oxygen availability
DE3882381D1 (en)
US4185116A (en) L- and DL- Phenylglycines to treat diseases or conditions attributable to reduced carbohydrate metabolism
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
US4439442A (en) Naftidrofuryl citrate and therapeutic applications
US4338319A (en) Method for the treatment of chronic obstructive airway or cardiac diseases
KR900003139A (en) Sulfonamides containing tetrazolyl groups, methods for their preparation, and pharmaceutical compositions containing them
US4179521A (en) L- and DL-Phenylglycines to treat diseases or conditions attributable to reduced carbohydrate metabolism
US4185117A (en) Method of treatment with glycinamides
HUT41781A (en) Process for producing new 1-alkyl-ergoline-thio-urea derivatives
SU1292730A1 (en) Method of determining the indication to use of calcium antagonists for patients ill with ischemia heart disease
ES8107191A1 (en) 2-(2-Chloro-4-cyclopropyl-phenyl-imino)-imidazolidine, its acid addition salts, medicaments containing the same and process for their preparation.
US4239779A (en) Use of phenylglyoxylic acids and derivatives thereof in the treatment of ischemic heart disease
EG16744A (en) Process for the preparation of 4-chlorophenoxy-acetate-1,3-bis dimethylamino-2-propyl-esters

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee